Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment.
- DOI
- 10.1038/s41598-022-14788-5
- Published
- 2022 Jul 5
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-022-14788-5,
title = {Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment.},
author = {Wallace-Povirk A and Rubinsak L and Malysa A and Dzinic SH and Ravindra M and Schneider M and Glassbrook J and O'Connor C and Hou Z and Kim S and Back J and Polin L and Morris RT and Gangjee A and Gibson H and Matherly LH},
year = {2022},
journal = {Scientific reports},
doi = {10.1038/s41598-022-14788-5},
url = {https://doi.org/10.1038/s41598-022-14788-5}
}RIS
TY - JOUR TI - Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment. AU - Wallace-Povirk A AU - Rubinsak L AU - Malysa A AU - Dzinic SH AU - Ravindra M AU - Schneider M AU - Glassbrook J AU - O'Connor C AU - Hou Z AU - Kim S AU - Back J AU - Polin L AU - Morris RT AU - Gangjee A AU - Gibson H AU - Matherly LH PY - 2022 JO - Scientific reports DO - 10.1038/s41598-022-14788-5 UR - https://doi.org/10.1038/s41598-022-14788-5 ER -
APA
A, W., L, R., A, M., SH, D., M, R., M, S., J, G., C, O., Z, H., S, K., J, B., L, P., RT, M., A, G., H, G., & LH, M. (2022). Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment.. Scientific reports. https://doi.org/10.1038/s41598-022-14788-5
Source records
- pubmed · retrieved 2026-11-10T13:35:33.937Z